| 标题： | 成人新型冠状病毒感染的急诊早期抗凝专家共识 |
| title： | Expert consensus on early anticoagulation of adult COVID-19 infection in emergency department |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 接诊新冠患者的急诊医师 |
| Guide users： | Emergency physician who treats patients with COVID-19 |
| 证据分级方法： | 证据水平 描述 低水平证据 将来的研究很可能对目前的评估结果有重要影响，从而很可能改变当前推荐 中等水平证据 将来的研究可能对目前的评估结果有重要影响，从而可能改变当前推荐 高水平证据 将来的研究几乎不可能改变当前的评估结果 |
| Evidence grading method： | Evidence level and description Low level evidence: future research is likely to have a significant impact on the current evaluation results, which could potentially alter the current recommendations. Moderate level of evidence: future research may have a significant impact on current evaluation results, which may alter current recommendations. High-level evidence: future research is almost impossible to change the current evaluation results. |
| 制定单位： | 中华医学会急诊医学分会 , 上海医学会急诊医学分会 |
| Formulating unit： | Emergency Medicine Branch of the Chinese Medical Association, Emergency Medicine Branch of the Shanghai Medical Association |
| 注册时间： | 2023-08-25 |
| Registration time： | |
| 注册编号： | PREPARE-2023CN631 |
| Registration number： | |
| 指南制订的目的： | 新冠患者除呼吸系统症状外，还可同时出现凝血、心血管、消化、泌尿、免疫等系统的损伤，甚至发生速发型多器官功能障碍综合征。已有研究表明，D-二聚体轻微升高时即进行抗凝治疗可显著改善组织灌注而保护多脏器功能，这是阻断新冠患者多脏器损伤的重要策略之一。新冠患者急诊就诊时的状态可分为发病早期和发病中后期，但对急诊医生来说，患者第一次医疗接触时，无论疾病处于哪个阶段，都属于早期（疾病早期或就诊早期），应根据疾病状态进行积极合理地抗凝，以尽早阻断多脏器损伤。 本共识旨在为急诊就诊的新冠患者如何抗凝提供依据。 |
| Purpose of the guideline： | In addition to respiratory symptoms, COVID-19 patients can also suffer from coagulation, cardiovascular, digestive, urinary, immune and other system injuries, and even rapid onset multiple organ dysfunction syndrome. Previous studies have shown that anticoagulant therapy can significantly improve tissue perfusion and protect multiple organ function when D-dimer slightly rises, which is one of the important strategies to block multiple organ injury in patients with COVID-19. The state of emergency treatment of COVID-19 patients can be divided into early onset and mid late onset. However, for emergency physicians, the first medical contact of patients, regardless of the stage of the disease, belongs to early stage (early disease or early treatment). Active and reasonable anticoagulation should be carried out according to the disease state to block multiple organ damage as soon as possible. This consensus is intended to provide basis for how to anticoagulate in COVID-19 patients in the ED. |
